

Recombinant Human TIMP-1 (Carrier-free)
Cat No. | Size | Price | Quantity | |
---|---|---|---|---|
21-7085-U002 | 2 µg | $76.00 | ||
21-7085-U010 | 10 µg | $179.00 | ||
21-7085-U100 | 100 µg | $955.00 | ||
21-7085-U500 | 500 µg | $2,860.00 |
Description
Product Details
Name | Recombinant Human TIMP-1 (Carrier-free) |
---|---|
Cat. No. | 21-7085 |
Alternative Names | Tissue inhibitor of metalloproteinases, Fibroblast collagenase inhibitor, Erythroid-potentiating activity |
Amino Acid Sequence | CTCVPPHPQT AFCNSDLVIR AKFVGTPEVN QTTLYQRYEI KMTKMYKGFQ ALGDAADIRF VYTPAMESVC GYFHRSHNRS EEFLIAGKLQ DGLLHITTCS FVAPWNSLSL AQRRGFTKTY TVGCEECTVF PCLSIPCKLQ SGTHCLWTDQ LLQGSEKGFQ SRHLACLPRE PGLCTWQSLR SQIA |
Authenticity | Verified by N-terminal and Mass Spectrometry analyses (when applicable). |
Bioactivity | TIMP1 activity was measured by its ability to inhibit human MMP-1 induced hydrolysis of a chromogenic peptide substrate at room temperature. Half maximal inhibition was obtained at a TIMP-1 concentration of approximately 0.5 µg/ml, when using an MMP-1 con |
Endotoxin Level | Endotoxin level is <0.1 ng/μg of protein (<1 EU/μg). |
Molecular Mass | Recombinant human TIMP-1 is a 20.6 kDa protein containing 184 amino acid residues. |
Protein Content | Content Verified by UV Spectroscopy and/or SDS-PAGE gel. |
Purity (%) | 95 |
Source | E. coli |
Reactivity | Human |
Research Areas | Angiogenesis/Cardiovascular; Inflammation; Proliferation; Stem Cells & Differentiation |
Reconstitution | See Certificate of Analysis (COA) for lot specific reconstitution information. |
Application | Bioassay |
FC = Flow Cytometry; FA = Functional Assays; ELISA = Enzyme-Linked Immunosorbent Assay; ICC = Immunocytochemistry; IF = Immunofluorescence Microscopy; IHC = Immunohistochemistry; IHC-F = Immunohistochemistry, Frozen Tissue; IHC-P = Immunohistochemistry, Paraffin-Embedded Tissue; IP = Immunoprecipitation; WB = Western Blot; EM = Electron Microscopy
*Tonbo Biosciences tests all antibodies by flow cytometry. Citations are provided as a resource for additional applications that have not been validated by Tonbo Biosciences. Please choose the appropriate format for each application and consult the Materials and Methods section for additional details about the use of any product in these publications.